179 related articles for article (PubMed ID: 35986199)
1. Bystander LECT2 amyloidosis in tumor nephrectomy.
Gallan AJ; Bhasin-Chhabra B; Kilari D; Johnson S; D'Souza A
CEN Case Rep; 2023 Feb; 12(1):104-109. PubMed ID: 35986199
[TBL] [Abstract][Full Text] [Related]
2. LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases.
Mejia-Vilet JM; Cárdenas-Mastrascusa LR; Palacios-Cebreros EJ; Reyes-Macedo M; Portilla-Jiménez A; Morales-Buenrostro LE; Cohen-Bucay A; Niño-Cruz JA; Uribe-Uribe NO
Am J Kidney Dis; 2019 Oct; 74(4):563-566. PubMed ID: 31155323
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series.
Murphy CL; Wang S; Kestler D; Larsen C; Benson D; Weiss DT; Solomon A
Am J Kidney Dis; 2010 Dec; 56(6):1100-7. PubMed ID: 20951486
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
5. Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in First Nations people in Northern British Columbia, Canada: a report of 4 cases.
Hutton HL; DeMarco ML; Magil AB; Taylor P
Am J Kidney Dis; 2014 Nov; 64(5):790-2. PubMed ID: 25064673
[TBL] [Abstract][Full Text] [Related]
6. Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.
Garcia-Roig M; Gorin MA; Parra-Herran C; Garcia-Buitrago M; Kava BR; Jorda M; Soloway MS; Manoharan M; Ciancio G
World J Urol; 2013 Aug; 31(4):835-9. PubMed ID: 21691720
[TBL] [Abstract][Full Text] [Related]
7. Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.
Wang X; Liu Q; Kong W; Huang J; Chen Y; Huang Y; Zhang J
BMC Cancer; 2017 Dec; 17(1):900. PubMed ID: 29282004
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of nontumoral renal pathologies in tumor nephrectomies: nontumoral renal parenchyma changes.
Sarsık B; Simşir A; Yılmaz M; Yörükoğlu K; Sen S
Ann Diagn Pathol; 2013 Apr; 17(2):176-82. PubMed ID: 23142019
[TBL] [Abstract][Full Text] [Related]
9. A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis.
Shye M; Sisk A; Schulze C; Barsoum M; Mikhail M; Arman F; Rastogi A; Hanna RM
Saudi J Kidney Dis Transpl; 2020; 31(2):508-514. PubMed ID: 32394925
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte chemotactic factor 2 associated renal amyloidosis: one case report].
Wang Y; Wang SX; Zhang YK
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):349-51. PubMed ID: 25882959
[TBL] [Abstract][Full Text] [Related]
11. Remission of nephrotic syndrome in amyloidosis associated with a hypernephroma.
Tang AL; Davies DR; Wing AJ
Clin Nephrol; 1989 Nov; 32(5):225-8. PubMed ID: 2582647
[TBL] [Abstract][Full Text] [Related]
12. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
[No Abstract] [Full Text] [Related]
13. Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico.
Larsen CP; Beggs ML; Wilson JD; Lathrop SL
Amyloid; 2016 Jun; 23(2):119-23. PubMed ID: 26912093
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract][Full Text] [Related]
15. A rare case of giant chromophobe renal cell carcinoma with sarcomatoid differentiation: Treatment and prognosis.
Mehra K; Manikandan R; Dorairajan LN; Sreerekha J
J Cancer Res Ther; 2021; 17(2):602-605. PubMed ID: 34121720
[TBL] [Abstract][Full Text] [Related]
16. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
[TBL] [Abstract][Full Text] [Related]
17. A rare case of bilateral synchronous renal tumors with different histology successfully treated with bilateral partial nephrectomy.
Dhanuka S; Kayal A; Mandal TK; Dhanuka J
J Cancer Res Ther; 2021; 17(2):593-595. PubMed ID: 34121717
[TBL] [Abstract][Full Text] [Related]
18. Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition.
Kowalski A; Cabrera J; Nasr S; Lerma E
Clin Nephrol; 2015 Oct; 84(4):236-40. PubMed ID: 26308079
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
[TBL] [Abstract][Full Text] [Related]
20. Amyloidoma of the kidney: a unique surgical case.
Ding Y; Yamada S; Wang KY; Shimajiri S; Guo X; Li Z; Sasaguri Y
Pathol Int; 2011 Jun; 61(6):387-9. PubMed ID: 21615617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
